JMP Sees A 'Negative Market Tone' In Biotechnology By: Benzinga via Benzinga June 15, 2015 at 13:31 PM EDT In a new report, analysts at JMP Securities focused on stocks and recent developments in the world of biotechnology. Overall, much of ... Read More >> Related Stocks: Acceleron Pharma Alnylam Pharmaceuticals Amgen Celgene Corp Incyte Corp Karyopharm Therapeut Merck & Co Regeneron Pharmaceuticals Sanofi-Aventis S.A. ADR